Keystone Symposia

Sustaining Sponsors


Donors making a three-year commitment of $25,000-$49,999 per year. Their generous support is crucial to Keystone Symposia's ability to plan future scientific conferences focused on emerging topics and excellence in science.

If your organization is interested in joining these entities in support of Keystone Symposia, please contact:

Development Office, Email: development@keystonesymposia.org, Phone:+1 970-262-2660

Click here for more information on Industry Support and Recognition Opportunities.
Astellas Pharma Inc. Autolus Therapeutics Bioverativ Therapeutics
BlueRock Therapeutics Boehringer Ingelheim Pharmaceuticals, Inc. ChemPartner
Compass Therapeutics Editas Medicine Gilead Sciences, Inc.
Moderna MorphoSys AG Nektar Therapeutics
Novartis Institutes for BioMedical Research Sanofi US Surface Oncology
TCR² Therapeutics Thermo Fisher Scientific Inc. Vertex Pharmaceuticals Incorporated



Sponsors


Donors contributing $25,000-$49,999. These generous gifts allow us to convene meetings in a wide variety of important areas, many of which are in the early stages of research. Special thanks to these organizations for consistent, annual Sponsor-level support.

If your organization is interested in joining these entities in support of Keystone Symposia, please contact:

Development Office, Email: development@keystonesymposia.org, Phone:+1 970-262-2660

Click here for more information on Industry Support and Recognition Opportunities.
10x Genomics AbbVie Inc. Akebia Therapeutics
Biogen Bristol-Myers Squibb Company Burroughs Wellcome Fund
Genmab A/S Ionis Pharmaceuticals, Inc. Educational grant from Lilly
TESARO, Inc.
Ultragenyx Pharmaceutical Inc.